Equideum Health is a pioneering company in the healthcare industry, with a focus on Web3 technologies. As a ConsenSys Mesh portfolio company and partner, formerly known as ConsenSys Health, Equideum Health is at the forefront of building Data Integrity and Learning Networks (DILNs). These networks prioritize populations with uniquely complex healthcare needs, aiming to improve population health and clinical outcomes by impacting access, equity, quality, personalization, engagement, and empowerment. The company's DILNs feature self-sovereign identity, fine-grained verifiable consents, advanced privacy preservation, and decentralized data liquidity across enterprise and individual data silos. Powered by Ethereum, tokenization, decentralized AI, and confidential computing, Equideum Health's Elevated ComputeTM platform is at the cutting edge of healthcare technology. A notable milestone for Equideum Health is its founding membership in the Decentralized Trials & Research Alliance (DTRA), where it is innovating in the field of privacy-preserving clinical trials matching, e-consent, and precision medicine applications. The company is an active participant in multiple Linux Foundation organizations, the Enterprise Ethereum Alliance, and IEEE SA Open initiatives, driving standards development and harmonization efforts necessary for the success of healthcare public-private partnerships in a Web3 world. With key partners including Oracle, Microsoft, and Intel, Equideum Health has positioned itself as a leader in leveraging emerging technologies for the advancement of healthcare. Since its establishment in 2018, Equideum Health continues to make significant strides in the fields of health care and Web3, making it an attractive prospect for potential investors.
There is no investment information
No recent news or press coverage available for Equideum Health.